X4 Pharmaceuticals Inc (NAS:XFOR) Stock News, Headlines & Updates
X4 Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jun 16, 2025
XFOR Presents Positive Phase 2 Trial Results for Mavorixafor at EHA Congress | XFOR Stock News
GuruFocus News • 7:32am
X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)
Marketwired • 7:00am
Jun 10, 2025
X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA | XFOR Stock News
GuruFocus News • 7:47am
X4 Pharmaceuticals (XFOR) Gains FDA Fast Track Status for Mavorixafor | XFOR Stock News
GuruFocus News • 7:33am
X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA
Marketwired • 7:00am
Jun 02, 2025
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | XFOR Stock News
GuruFocus News • 3:17pm
May 14, 2025
X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress
Marketwired • 4:00pm
X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress | XFOR Stock News
GuruFocus News • 3:35pm
May 02, 2025
XFOR: HC Wainwright Raises Price Target for X4 Pharmaceuticals | XFOR Stock News
GuruFocus News • 8:37am
XFOR: Price Target Raised as Phase 3 Study Progresses | XFOR Stock News
GuruFocus News • 5:32am
X4 Pharmaceuticals Inc (XFOR) Q1 2025 Earnings Call Highlights: Progress in Maverick 4 Development and Strategic Partnerships
GuruFocus News • 1:06am
Q1 2025 X4 Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News • 11:17pm
May 01, 2025
X4 Pharmaceuticals (XFOR) Posts Strong Q1 Results with Notable Cash Position
GuruFocus News • 6:00am
X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
Marketwired • 6:00am
X4 Pharmaceuticals Inc (XFOR) Q1 2025 Earnings: EPS of $0.04 Beats Estimate, Revenue Soars to $28.8 Million
GuruFocus News • 5:52am
XFOR Q1 Revenue Surges to $28.8 Million, Spotlighting Significant Progress | XFOR Stock News
GuruFocus News • 5:32am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news